ATE425970T1 - Testverfahren mit verbesserten chemilumineszierenden estern, thioestern und amiden - Google Patents

Testverfahren mit verbesserten chemilumineszierenden estern, thioestern und amiden

Info

Publication number
ATE425970T1
ATE425970T1 AT98123411T AT98123411T ATE425970T1 AT E425970 T1 ATE425970 T1 AT E425970T1 AT 98123411 T AT98123411 T AT 98123411T AT 98123411 T AT98123411 T AT 98123411T AT E425970 T1 ATE425970 T1 AT E425970T1
Authority
AT
Austria
Prior art keywords
ring
linkage
ring system
substituent groups
heterocyclic ring
Prior art date
Application number
AT98123411T
Other languages
English (en)
Inventor
Frank Mccapra
Iraj Beheshti
Russell C Hart
Harlen Koelling
Ashokkumar Patel
Kastooriranganathan Ramakrishnan
Original Assignee
Nichols Inst Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26837818&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE425970(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nichols Inst Diagnostics filed Critical Nichols Inst Diagnostics
Application granted granted Critical
Publication of ATE425970T1 publication Critical patent/ATE425970T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT98123411T 1987-12-31 1988-12-30 Testverfahren mit verbesserten chemilumineszierenden estern, thioestern und amiden ATE425970T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14004087A 1987-12-31 1987-12-31
US29184388A 1988-12-29 1988-12-29

Publications (1)

Publication Number Publication Date
ATE425970T1 true ATE425970T1 (de) 2009-04-15

Family

ID=26837818

Family Applications (2)

Application Number Title Priority Date Filing Date
AT88121915T ATE183311T1 (de) 1987-12-31 1988-12-30 Für tests verwendbare chemilumineszierende ester, thioester und amide
AT98123411T ATE425970T1 (de) 1987-12-31 1988-12-30 Testverfahren mit verbesserten chemilumineszierenden estern, thioestern und amiden

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT88121915T ATE183311T1 (de) 1987-12-31 1988-12-30 Für tests verwendbare chemilumineszierende ester, thioester und amide

Country Status (14)

Country Link
EP (2) EP0322926B2 (de)
JP (1) JP3172522B2 (de)
KR (1) KR900700888A (de)
AT (2) ATE183311T1 (de)
AU (1) AU635890B2 (de)
CA (1) CA1341613C (de)
DE (3) DE3856358T3 (de)
ES (1) ES2134185T5 (de)
GB (4) GB2232995B (de)
GR (1) GR3031647T3 (de)
IE (1) IE61614B1 (de)
IL (1) IL88848A (de)
NZ (1) NZ227506A (de)
WO (1) WO1989006231A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918192A (en) * 1986-10-06 1990-04-17 Ciba Corning Diagnostics Corp. Polysubstituted aryl acridinium esters
EP0273115B1 (de) * 1986-10-22 1994-09-07 Abbott Laboratories Chemilumineszierende Acridinium- und Phenantridiniumsalze
US4950613A (en) * 1988-02-26 1990-08-21 Gen-Probe Incorporated Proteted chemiluminescent labels
JP2681061B2 (ja) * 1988-06-08 1997-11-19 ロンドン・ダイアグノスティック・インコーポレーテッド 検出可能なシグナルのセンシタイザー誘導発生を利用したアッセイ
US5656426A (en) * 1988-08-01 1997-08-12 Chiron Diagnostics Corporation Functionaized hydrophilic acridinium esters
US5227489A (en) * 1988-08-01 1993-07-13 Ciba Corning Diagnostics Corp. Stable hydrophilic acridinium esters suitable for liposome encapsulation
CA1339491C (en) * 1988-09-26 1997-10-07 Say-Jong Law Nucleophilic polysubstituted aryl acridinium ester and uses thereof
US5663074A (en) * 1988-09-26 1997-09-02 Chiron Diagnostics Corporation Nucleophilic polysubstituted aryl acridinium ester conjugates and syntheses thereof
US5340716A (en) * 1991-06-20 1994-08-23 Snytex (U.S.A.) Inc. Assay method utilizing photoactivated chemiluminescent label
US6002000A (en) * 1992-07-20 1999-12-14 Dade Behring Marburg Gmbh Chemiluminescent compounds and methods of use
CA2140661A1 (en) * 1992-07-20 1994-02-03 Sharat Singh Novel chemiluminescent compounds and methods of use
ATE162892T1 (de) * 1992-07-31 1998-02-15 Behringwerke Ag Photoaktivierbare chemiluminizierende matrices
JP3584379B2 (ja) * 1993-02-04 2004-11-04 持田製薬株式会社 アクリジニウム化合物およびアクリジニウム化合物複合体
US5395752A (en) * 1993-03-19 1995-03-07 Ciba Corning Diagnostics Corp. Long emission wavelength chemiluminescent compounds and their use in test assays
US5491072A (en) * 1993-05-17 1996-02-13 Lumigen, Inc. N-alkylacridan carboxyl derivatives useful for chemiluminescent detection
US5393891A (en) * 1993-06-08 1995-02-28 The Du Pont Merck Pharmaceutical Company Immunoassay reagents and methods for detecting brequinar and analogs
US5731148A (en) * 1995-06-07 1998-03-24 Gen-Probe Incorporated Adduct protection assay
EP0761652A1 (de) * 1995-08-01 1997-03-12 Mochida Pharmaceutical Co., Ltd. Acridiniumverbindung mit mehreren lumineszierenden Gruppen und Bindungsgruppen und Konjugate derselben
PT915851E (pt) * 1996-07-16 2002-09-30 Staat Nl Verteg Door Min Welzi Esteres dibenzodihidropiridinecarboxilicos e seu uso no ensaio dos metodos quimiluminiscente
US6165800A (en) * 1997-05-30 2000-12-26 Bayer Corporation Chemiluminescent energy transfer conjugates and their uses as labels in binding assays
EP1019379B1 (de) * 1997-08-21 2005-10-19 Maine Medical Center Auf peroxiden basierender chemilumineszenztest und chemilumineszente verbindungen die in diesem benutzt werden
US6723851B2 (en) * 2001-10-31 2004-04-20 Quest Diagnostics Investment Incorporated Chemiluminescent compounds and use thereof
DE102005020384A1 (de) * 2005-05-02 2006-11-09 Therainvention Gmbh Spektroskopisches Verfahren zum Nachweis von Analyten

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1461877A (en) * 1974-02-12 1977-01-19 Wellcome Found Assay method utilizing chemiluminescence
GB2112779B (en) * 1981-12-11 1986-10-15 Welsh Nat School Med Aryl acridinium esters as luminescent labelling materials
US4687747A (en) * 1984-07-02 1987-08-18 Mallinckrodt, Inc. Phenanthridinium ester as a labelling compound in luminometric immunoassay
JPS6261969A (ja) * 1985-09-06 1987-03-18 アモコ・コーポレーション アクリジニウムエステルの合成法
DE3645292C2 (de) * 1986-08-22 1997-12-11 Hoechst Ag Chemilumineszenzimmunoassays und ein Verfahren zu ihrer Herstellung
US4745181A (en) * 1986-10-06 1988-05-17 Ciba Corning Diagnostics Corp. Polysubstituted aryl acridinium esters
EP0273115B1 (de) * 1986-10-22 1994-09-07 Abbott Laboratories Chemilumineszierende Acridinium- und Phenantridiniumsalze
ATE124143T1 (de) * 1987-09-21 1995-07-15 Gen Probe Inc Homogener abschirmungstest.
NL8703075A (nl) † 1987-12-18 1989-07-17 Nederlanden Staat Acridiniumverbindingen als chemiluminescentie-merkstof.

Also Published As

Publication number Publication date
DE3856358D1 (de) 1999-09-16
EP0322926B1 (de) 1999-08-11
GB9203179D0 (en) 1992-04-01
GR3031647T3 (en) 2000-02-29
AU2927089A (en) 1989-08-01
ATE183311T1 (de) 1999-08-15
GB9014479D0 (en) 1990-10-03
ES2134185T3 (es) 1999-10-01
AU635890B2 (en) 1993-04-08
NZ227506A (en) 1992-06-25
EP0916658B1 (de) 2009-03-18
IL88848A (en) 1994-02-27
GB9203181D0 (en) 1992-04-01
EP0322926A2 (de) 1989-07-05
EP0322926B2 (de) 2004-03-31
JP3172522B2 (ja) 2001-06-04
GB2232995A (en) 1991-01-02
IE883895L (en) 1989-06-30
GB2232995B (en) 1992-10-14
ES2134185T5 (es) 2004-11-01
EP0322926A3 (de) 1991-03-20
JPH03501772A (ja) 1991-04-18
GB2251942A (en) 1992-07-22
IE61614B1 (en) 1994-11-16
DE3856597D1 (de) 2009-04-30
IL88848A0 (en) 1989-07-31
KR900700888A (ko) 1990-08-17
DE3891212T1 (de) 1991-01-10
DE3856358T2 (de) 2000-04-20
GB9203180D0 (en) 1992-04-01
WO1989006231A1 (en) 1989-07-13
DE3856358T3 (de) 2004-12-30
GB2252162A (en) 1992-07-29
GB2252161A (en) 1992-07-29
EP0916658A1 (de) 1999-05-19
CA1341613C (en) 2011-05-10

Similar Documents

Publication Publication Date Title
ATE425970T1 (de) Testverfahren mit verbesserten chemilumineszierenden estern, thioestern und amiden
ATE177743T1 (de) Langkettiger carbonsäureimidester
DK0526642T3 (da) Triterpenderivat
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
GB1490603A (en) Glycerides with anti-inflammatory properties
SE7712630L (sv) Forfarande for framstellning av o-alkylerade hydroxylaminer
ATE38675T1 (de) Phosphatesterderivate und ihre verwendung als anti-krebsmittel.
GB1514389A (en) Glycerides with antibacterial properties
DE3777325D1 (de) 2-amino-4-phosphonyl-buttersaeurederivate und herstellung von 2-amino-4-phosphinyl-butter-saeuren.
PT88463A (pt) Process for the preparation of macrolide compounds and of compositions containing them
ATE115951T1 (de) Glycocyamidin-derivate.
FR2336409A1 (fr) Melanges d'esters phosphoreux utilisables comme stabilisants de matieres organiques
DK564788A (da) 2-azetidinon-derivater
SE7900889L (sv) Sett att framstella xantonderivat
ATE967T1 (de) Verfahren zur herstellung von xanthonderivaten.
ES466305A1 (es) Un procedimiento para la preparacion de una sal con un ami- noazucar basico o un aminoacido basico, de un derivado de benzopirano.
TH22461A (th) อนุพันธ์พิเพอร์คิล-ไทรอาซีน ชนิดใหม่และการใช้สารทำให้โพทำให้โพลิเมอร์เสถียร
ATE14T1 (de) Thiolphosphorsaeure-s-4-nitro-2trichlormethylphenyl-ester, ihre herstellung und verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties